• Erbium:YAG laser aids transdermal drug delivery

    Researchers from Venisect (Little Rock, AR) have shown that using an Er:YAG laser (with output at 2.94 µm) to alter the outermost layer of human skin significantly improves the ability to transdermally deliver a wide range of drugs, including insulin, interferon, hydrocortisone, and a lidocaine solution, without the need for needles and syringes. Historically, only a limited number of drugs have been delivered transdermally because the majority are unable to pass through the skin`s surface.
    April 1, 1996

    Erbium:YAG laser aids transdermal drug delivery

    Researchers from Venisect (Little Rock, AR) have shown that using an Er:YAG laser (with output at 2.94 µm) to alter the outermost layer of human skin significantly improves the ability to transdermally deliver a wide range of drugs, including insulin, interferon, hydrocortisone, and a lidocaine solution, without the need for needles and syringes. Historically, only a limited number of drugs have been delivered transdermally because the majority are unable to pass through the skin`s surface. Venisect and LaBarge (St. Louis, MO) have been jointly developing an erbium-laser blood-drawing device since 1993; this laser was modified for use in the transdermal applications. Clinical trials are now under way.

    Sign up for Laser Focus World Newsletters
    Get the latest news and updates.

    Related

    Case Study: Custom Microlens Arrays Design
    High-Precision Optical Design for Wide Spectrum Star Trackers | Avantier
    Hexapod 6-DOF Active Optical Alignment Micro-Robots - Enablers for Advanced Camera Manufacturing
    Sponsored
    Laser Assisted Wafer Slicing with 3DOF Motion Stages
    Sponsored

    Voice Your Opinion!

    To join the conversation, and become an exclusive member of Laser Focus World, create an account today!